Celltrion
068270.KS
#855
Rank
$29.28 B
Marketcap
$127.72
Share price
-2.41%
Change (1 day)
1.61%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2026 (TTM): $2.53

According to Celltrion 's latest financial reports the company's current EPS (TTM) is $2.53. In 2025 the company made an earnings per share (EPS) of $3.09 an increase over its 2024 EPS that were of $1.17.

EPS history for Celltrion from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)$2.53-18.27%
2025$3.09163.66%
2024$1.17-53.73%
2023$2.53-2.08%
2022$2.59-11.72%
2021$2.932.03%
2020$2.8782.8%
2019$1.5718.31%
2018$1.33-36.33%
2017$2.09161.25%
2016$0.802.86%
2015$0.7817.84%
2014$0.665.87%
2013$0.62-70.85%
2012$2.14134.09%
2011$0.9143.59%
2010$0.6474.49%
2009$0.36317.8%
2008$0.08714-71.7%
2007$0.31